Cart
sales@molnova.com
Acegastrodine
CAS No. 64291-41-4
Acegastrodine( —— )
Catalog No. M21525 CAS No. 64291-41-4
Acetagastrodin has an antispasmodic effect on vascular smooth muscle.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 29 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAcegastrodine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcetagastrodin has an antispasmodic effect on vascular smooth muscle.
-
DescriptionAcetagastrodin has an antispasmodic effect on vascular smooth muscle.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64291-41-4
-
Formula Weight454.4
-
Molecular FormulaC21H26O11
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(OC[C@H]([C@H]([C@@H]([C@H]1OC(C)=O)OC(C)=O)OC(C)=O)O[C@H]1Oc1ccc(CO)cc1)=O
-
Chemical Name(2R3R4S5R6S)-2-(acetoxymethyl)-6-(4-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-345-triyl triacetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Xiaochun Yang et al. Acetagastrodin Effects on Retinal Oscillatory Potentials in Patients During the Early Stages of Diabetes. Acta Diabetol. 2017 Jan;54(1):73-79.
molnova catalog
related products
-
Ralinepag
Ralinepag is a potent, orally bioavailable and non-prostanoid prostacyclin (IP) receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively.
-
Lucidumol A
Lucidumol A has relatively good effect against aldose reductase with IC50 of 19.1uM. Lucidumol A has cytotoxic activity, it reduced cell growth in three human carcinoma cells (Caco-2, HepG2, and HeLa cells) dose dependently with LC50s from 20.87 to 84.36 uM.
-
Gigantol
Gigantol is a novel inhibitor of the Wnt/β-catenin pathway. It inhibits Wnt/β-catenin signaling through downregulation of phosphorylated LRP6 and cytosolic β-catenin in breast cancer cells.
